Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists

Azanoradamantanes for treatment of conditions responsive to 5-HT agonists and/or antagonists

US Patent 5446049 · Granted Aug 29, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating disorders using CSF1R inhibitors2025
Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof2025
Anti-viral activity of VPS34 inhibitors2025
Aminopyrimidine amide autophagy inhibitors and methods of use thereof2025
RAF kinase inhibitors and methods of use thereof2025
Methods of treating disorders using CSF1R inhibitors2025
Combination therapy for the treatment of mastocytosis2024
Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof2024
Combination therapy for the treatment of gastrointestinal stromal tumor2024
GCN2 and perk kinase inhibitors and methods of use thereof2024
Anti-viral activity of VPS34 inhibitors2023
Methods of treating disorders using CSF1R inhibitors2023